Contact
Please use this form to send email to PR contact of this press release:
Regulatory update: GlaxoSmithKline receives complete response from FDA for candidate pandemic H5N1 adjuvanted influenza vaccine
TO:
Please use this form to send email to PR contact of this press release:
Regulatory update: GlaxoSmithKline receives complete response from FDA for candidate pandemic H5N1 adjuvanted influenza vaccine
TO: